LINE

Text:AAAPrint
Society

FDA approves HPV vaccine for adults aged 27 to 45

1
2018-10-07 09:29:21Xinhua Editor : Li Yan ECNS App Download

The United States Food and Drug Administration has recently approved the expanded use of a HPV vaccine to include women and men aged 27 through 45 years.

Gardasil 9 is used to prevent certain cancers and diseases caused by the nine Human Papillomavirus (HPV) types covered by the vaccine but previously applied only for those aged nine through 26 years.

Every year about 14 million Americans become infected with HPV and about 12,000 women are diagnosed with and about 4,000 women die from cervical cancer caused by certain HPV viruses, according to the country's Centers for Disease Control and Prevention.

In a study in approximately 3,200 women 27 through 45 years of age, followed for an average of 3.5 years, Gardasil was 88 percent effective in preventing symptoms related to HPV types covered by the vaccine.

Effectiveness of Gardasil 9 in men 27 through 45 years of age is inferred from the data described in women 27 through 45 years of age, as well as efficacy data from Gardasil in younger men (16 through 26 years of age) and immunogenicity data from a clinical trial in which 150 men, 27 through 45 years of age, received a three-dose regimen of Gardasil over six months.

  

Related news

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

News
Politics
Business
Society
Culture
Military
Sci-tech
Entertainment
Sports
Odd
Features
Biz
Economy
Travel
Travel News
Travel Types
Events
Food
Hotel
Bar & Club
Architecture
Gallery
Photo
CNS Photo
Video
Video
Learning Chinese
Learn About China
Social Chinese
Business Chinese
Buzz Words
Bilingual
Resources
ECNS Wire
Special Coverage
Infographics
Voices
LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2018 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.